E33039 IAEA NPC - TROG Cancer Research

By Narelle Williams
31 January, 2022
0 Comments

A Situation Analysis of National Radiotherapy Resources and Patterns of Care for Patients with Nasopharyngeal Carcinoma in Low-Middle Income Countries: Can Enhancing the Quality of Radiotherapy Planning Improve Outcomes

Primary Sponsor

Collaborating Groups

TROG Cancer Research

Trial Chairperson

Anne W.M. Lee, University of Hong Kong
June Corry, Peter MacCallum Cancer Centre, Melbourne, Australia

Trial Contact

qa@trog.com.au

24 June, 2025

TROG 2024 Annual Research Report highlights a year of achievements

LATEST NEWS: 24 JUNE 2025 The latest annual report

11 June, 2025

Trial Could Prove a Game-Changer for Treating High-Risk Skin Cancer

LATEST NEWS: 11 JUNE 2025 New findings from a

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

A Situation Analysis of National Radiotherapy Resources and Patterns of Care for Patients with Nasopharyngeal Carcinoma in Low-Middle Income Countries: Can Enhancing the Quality of Radiotherapy Planning Improve Outcomes

E33036 IAEA HCC

TROG 21.12 – ASPIRE

Related Post

TROG 2024 Annual Research Report highlights a year of achievements

Trial Could Prove a Game-Changer for Treating High-Risk Skin Cancer